Search research articles
Contact Us
Filters
Showing results (131-140 of 184) with videos related to
Page
of 19
Sort By:
Bone Marrow Transplantation
|
January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party
Olaf Penack, Christophe Peczynski, William Boreland, et al.
Mycoses
|
August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Bone Marrow Transplantation
|
July 17, 2024
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
Lars Klingen Gjærde, Oscar Brück, Nico Gagelmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2023
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
Jiaqi Fan, Anne Adams, Noëlle Sieg, et al.
Journal of the National Cancer Institute
|
May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
Olaf Penack, Erik Henke, David Suh, et al.
The Lancet. Haematology
|
February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Transfusion
|
July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells
Vladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Annals of the Rheumatic Diseases
|
February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
Ioanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Hemasphere
|
July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Veit Bücklein, Ariel Perez, Kai Rejeski, et al.
Blood Advances
|
January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre study
Nina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 184) with videos related to
Sort By:
Page
of 19
Bone Marrow Transplantation
|
January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party
Olaf Penack, Christophe Peczynski, William Boreland, et al.
Mycoses
|
August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Bone Marrow Transplantation
|
July 17, 2024
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
Lars Klingen Gjærde, Oscar Brück, Nico Gagelmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2023
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
Jiaqi Fan, Anne Adams, Noëlle Sieg, et al.
Journal of the National Cancer Institute
|
May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
Olaf Penack, Erik Henke, David Suh, et al.
The Lancet. Haematology
|
February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Transfusion
|
July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells
Vladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Annals of the Rheumatic Diseases
|
February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
Ioanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Hemasphere
|
July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Veit Bücklein, Ariel Perez, Kai Rejeski, et al.
Blood Advances
|
January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre study
Nina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Page
of 19